Midlatency auditory-evoked potentials in the assessment of sedation in cardiac surgery patients

J Cardiothorac Vasc Anesth. 2004 Oct;18(5):559-62. doi: 10.1053/j.jvca.2004.07.008.

Abstract

Objectives: Midlatency auditory-evoked potentials (MLAEPs) may provide an objective measure of depth of sedation. The aim of this study was to evaluate MLAEPs for measuring sedation in cardiac surgery patients.

Design: Prospective study.

Setting: Intensive care unit of a university hospital.

Participants: Twenty-two patients scheduled for elective coronary artery bypass grafting.

Interventions: MLAEPs were obtained at 5 time points: the day before surgery (baseline), 1 hour before surgery, after premedication, postoperatively during deep (Ramsay 6) and moderate (Ramsay 4) sedation, and the day after surgery.

Measurements and main results: The latency of the Nb MLAEP component increased from 44 ms (38-60 ms; median, range) at baseline to 49 ms (41-64 ms) after premedication (p = 0.03) and further to 63 ms (48-80 ms) during deep sedation after surgery (P < 0.01). Although a decreasing clinical level of sedation after rewarming was not associated with a significant change in Nb latency (61 ms [42-78 ms]), the MLAEP NaPa amplitude increased from 0.9 muV (0.4-1.6 microV) to 1.3 muV (0.8-3.9 microV; p = 0.01). Nb latency remained increased the day after surgery (49 ms [37-71 ms]) as compared with baseline (p < 0.01).

Conclusions: MLAEP latencies can reflect subtle changes in auditory perception, while amplitudes seem to change with transition between deep levels of sedation.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alfentanil / therapeutic use
  • Anesthetics, Intravenous / therapeutic use
  • Cardiopulmonary Bypass / methods
  • Conscious Sedation / methods*
  • Conscious Sedation / statistics & numerical data
  • Coronary Artery Bypass / methods*
  • Diazepam / therapeutic use
  • Evoked Potentials, Auditory / drug effects*
  • Evoked Potentials, Auditory / physiology
  • Female
  • Humans
  • Male
  • Midazolam / therapeutic use
  • Middle Aged
  • Neuromuscular Nondepolarizing Agents / therapeutic use
  • Pancuronium / therapeutic use
  • Propofol / therapeutic use
  • Prospective Studies

Substances

  • Anesthetics, Intravenous
  • Neuromuscular Nondepolarizing Agents
  • Alfentanil
  • Pancuronium
  • Diazepam
  • Midazolam
  • Propofol